Background: Adenoidectomy is a common surgical intervention for treating adenoid hypertrophy in pediatric patients. Traditional methods such as curettage and electrocautery are effective but often associated with bleeding, thermal injury, and delayed recovery. Microdebrider-assisted coblation adenoidectomy is an innovative approach that combines precise tissue shaving with controlled low-temperature ablation for improved outcomes.

Objective: To evaluate the efficacy, safety, and clinical outcomes of microdebrider-assisted coblation adenoidectomy in pediatric patients.

Methods: A prospective study was conducted on seventy pediatric patients aged 4.3 to 11.7years with symptomatic adenoid hypertrophy. All patients underwent microdebrider-assisted coblation adenoidectomy. The primary outcomes measured included operative time, intraoperative blood loss, postoperative pain (using the Visual Analog Scale), recovery time, and complications. Data were analyzed using descriptive and inferential statistics, with significance set at p < 0.05.

Results: The mean operative time was 53.54 minutes. Mean intraoperative blood loss was 6.5 ± 4.8 mL. Recovery time to normal activities was 5.3 ± 1.4 days. No significant complications, such as severe bleeding or infections, were observed.

Conclusion: Microdebrider-assisted coblation adenoidectomy is a secure, efficient, and less-invasive technique for adenoid removal. It is a good option for pediatric patients because it provides better visualization, less intraoperative blood loss, less postoperative pain, and a quicker recovery.